LOUD Capital

10XTS designs and develops blockchain solutions that blend enterprise architecture, software development, data science, and artificial intelligence to help organizations implement and manage digital assets. Its offerings include xtsCore, a suite of infrastructure, software, and data modules that accelerate blockchain projects; xtsConnect, providing consulting to design blockchain solutions; and xtsLaunch, which delivers product management and marketing support for token launches. The company’s flagship XDEX crypto asset management cloud enables tokenization of real-world assets, while its software also supports record management and information governance for digital assets in financial services and capital markets, driven by interoperable standards and processes aimed at improving automation, efficiency, and trust.

SafeWire, a company founded in 2016 and headquartered in Westerville, Ohio, specializes in developing software solutions aimed at preventing fraud in property transactions. Catering primarily to title service offices, mortgage bankers, and realtors, SafeWire's offerings include a comprehensive suite of features designed to enhance security and efficiency in real estate dealings. The software addresses critical areas such as reducing closing times, minimizing fraudulent liabilities, and streamlining manual due diligence processes. Key functionalities include client identity verification, ownership verification of bank accounts, and the protection of wire transactions, all leveraging blockchain technology to ensure robust security measures.

10XTS designs and develops blockchain solutions that blend enterprise architecture, software development, data science, and artificial intelligence to help organizations implement and manage digital assets. Its offerings include xtsCore, a suite of infrastructure, software, and data modules that accelerate blockchain projects; xtsConnect, providing consulting to design blockchain solutions; and xtsLaunch, which delivers product management and marketing support for token launches. The company’s flagship XDEX crypto asset management cloud enables tokenization of real-world assets, while its software also supports record management and information governance for digital assets in financial services and capital markets, driven by interoperable standards and processes aimed at improving automation, efficiency, and trust.

SafeWire, a company founded in 2016 and headquartered in Westerville, Ohio, specializes in developing software solutions aimed at preventing fraud in property transactions. Catering primarily to title service offices, mortgage bankers, and realtors, SafeWire's offerings include a comprehensive suite of features designed to enhance security and efficiency in real estate dealings. The software addresses critical areas such as reducing closing times, minimizing fraudulent liabilities, and streamlining manual due diligence processes. Key functionalities include client identity verification, ownership verification of bank accounts, and the protection of wire transactions, all leveraging blockchain technology to ensure robust security measures.

Founded in 2014, Rekovo develops Agile Arts, a web-based technology that transforms patient movements into artwork. It improves patient engagement and compliance with exercise prescriptions, tracking session data and benefiting patients with balance deficits, neurological disorders, and other conditions. Serving caregivers worldwide.

Genetesis LLC, established in 2013 and based in Mason, Ohio, specializes in designing, developing, and providing biomagnetic imaging solutions for cardiac healthcare. The company's primary product is Genetesis CardioFlux, a mapping system that optimizes the detection, characterization, and treatment of cardiac rhythm disorders by visualizing electrical currents of the heart in 3D. Additionally, they offer Faraday Analytical Cloud, a HIPAA-compliant platform managing end-to-end data workflow for their Magnetocardiograph (MCG). Genetesis aims to redefine clinical diagnosis, monitoring, and screening processes for patients at risk of myocardial ischemia and coronary artery disease, using non-invasive, radiation-free methods.